Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Auerbach Insider Profile
4 Followers
Mark Auerbach, Director at RCS Capital, holds 0.00 shares in Pardes Biosciences (Ticker: PRDS), holds 112.04K shares in RCS Capital (Ticker: RCAPQ), holds 0.00 shares in Optimer Pharma (Ticker: OPTR).
Mark Auerbach RCS Capital (RCAPQ)Director
RCS Capital (RCAPQ)
Director
Not Ranked
Mark Auerbach has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Mark Auerbach does not currently own shares as a corporate insider.
A breakdown of Mark Auerbach's holdings
Insider Roles
Director
Roles that Mark Auerbach holds in companies
Most Profitable Insider Trade
Stock:
RCS Capital
(RCAPQ)
(RCAPQ)
Rating:Informative Buy
Date:Jun 09, 2014 - Jun 09, 2015
Return:-61.70%
The most profitable trade made by Mark Auerbach
Mark Auerbach's Trading History
RCS Capital
Dec 28, 2015
―
Uninformative Sell
229.47K
$560.20
Pardes Biosciences
Aug 31, 2023
―
Uninformative Sell
―
$0.00
Optimer Pharma
―
―
―
―
Par Pharmaceutical Cos. Inc.
―
―
―
―
Assembly Biosciences
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Mark Auerbach's performance on stock
You May Also Like
Mark Auerbach insider profile FAQ
What is the percentage of profitable transactions made by Mark Auerbach?
The percentage of profitable transactions made by Mark Auerbach is ―.
What is the average return per transaction made by Mark Auerbach?
The average return per transaction made by Mark Auerbach is ―.
What stocks does Mark Auerbach hold?
Mark Auerbach holds: RCAPQ, PRDS, OPTR, PRX, ASMB stocks.
What was Mark Auerbach’s latest transaction?
Mark Auerbach latest transaction was an Uninformative Sell of ―.
What was Mark Auerbach's most profitable transaction?
Mark Auerbach’s most profitable transaction was an Informative Buy of RCAPQ stock on June 9, 2014. The return on the trade was -61.70%.
What is Mark Auerbach's role in RCS Capital?
Mark Auerbach's role in RCS Capital is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.